| |
| |
|
| Insider
Information: |
Shanafelt Armen |
| Relationship: |
Director, 10% Owner |
| City: |
Indianapolis |
| State: |
IN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
150,000 |
|
|
Indirect Shares
|
8,710,829 |
|
|
| Direct
Value |
$90,105 |
|
|
|
Indirect Value
|
$68,302,696 |
|
|
| Total
Shares |
8,860,829 |
|
|
| Total
Value |
$68,392,801 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
3
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-3.0
|
0.0
|
| Percentage
Gain/Loss : |
 -85.8%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aeglea Biotherapeutics, Inc. |
AGLE |
Director |
2021-12-13 |
150,000 |
2016-04-12 |
2,068,543 |
Premium* |
|
|
Protagonist Therapeutics, Inc |
PTGX |
Director, 10% Owner |
2016-08-16 |
0 |
2016-08-16 |
2,099,482 |
Premium* |
|
|
Aileron Therapeutics Inc |
ALRN |
Director |
2017-07-05 |
0 |
2017-07-05 |
1,094,987 |
Premium* |
|
|
Surface Oncology, Inc. |
SURF |
Director, 10% Owner |
2018-04-23 |
0 |
2018-04-23 |
3,447,817 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AGLE |
Aeglea Biotherapeutics, I... |
Director |
– • – |
2021-12-13 |
4 |
B |
$3.65 |
$53,600 |
D/D |
14,685 |
150,000 |
2.39 |
% |
|
| AGLE |
Aeglea Biotherapeutics, I... |
Director |
– • – |
2021-12-10 |
4 |
B |
$3.65 |
$49,333 |
D/D |
13,516 |
135,315 |
2.39 |
% |
|
| AGLE |
Aeglea Biotherapeutics, I... |
Director |
– • – |
2021-12-09 |
4 |
B |
$3.67 |
$446,759 |
D/D |
121,799 |
121,799 |
2.39 |
% |
|
| SURF |
Surface Oncology, Inc. |
Director |
– • • |
2018-04-23 |
4 |
B |
$15.00 |
$3,990,000 |
I/I |
266,000 |
3,447,817 |
2.25 |
- |
|
| SURF |
Surface Oncology, Inc. |
Director |
– • • |
2018-04-23 |
4 |
A |
$0.00 |
$0 |
I/I |
3,181,817 |
3,181,817 |
0 |
- |
|
| ALRN |
Aileron Therapeutics Inc |
Director |
– • – |
2017-07-05 |
4 |
B |
$15.00 |
$3,750,000 |
I/I |
250,000 |
1,094,987 |
2.1 |
- |
|
| ALRN |
Aileron Therapeutics Inc |
Director |
– • – |
2017-07-05 |
4 |
A |
$0.00 |
$0 |
I/I |
844,987 |
844,987 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
Director |
– • • |
2016-08-16 |
4 |
B |
$12.00 |
$6,999,996 |
I/I |
583,333 |
2,099,482 |
2.25 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
Director |
– • • |
2016-08-16 |
4 |
A |
$0.00 |
$0 |
I/I |
1,516,149 |
1,516,149 |
0 |
- |
|
| AGLE |
Aeglea Biotherapeutics, I... |
10% Owner |
– – • |
2016-04-12 |
4/A |
A |
$0.00 |
$0 |
I/I |
2,010,924 |
2,068,543 |
0 |
- |
|
| AGLE |
Aeglea Biotherapeutics, I... |
Director |
– • • |
2016-04-06 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
57,619 |
|
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
